Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000695594 | SCV000824104 | likely benign | Familial infantile myasthenia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532311 | SCV003683974 | uncertain significance | Inborn genetic diseases | 2021-06-22 | criteria provided, single submitter | clinical testing | The c.1174G>A (p.A392T) alteration is located in exon 8 (coding exon 8) of the CHAT gene. This alteration results from a G to A substitution at nucleotide position 1174, causing the alanine (A) at amino acid position 392 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000695594 | SCV003833236 | uncertain significance | Familial infantile myasthenia | 2022-12-21 | criteria provided, single submitter | clinical testing |